Novo Nordisk launches a $499 monthly plan for Ozempic to help U.S. patients struggling with high out-of-pocket drug costs. Novo Nordisk, the global pharmaceutical giant behind the popular diabetes and weight-loss drug
Talks stall as Kinshasa and M23 rebels remain divided on disarmament and political guarantees. The Democratic Republic of Congo’s long-running conflict took another uncertain turn as the government and M23 rebels failed